ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
PO Box 28,
South Australia 5007
19 North Terrace,
Hackney, SA, 5069
1300 128 339
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
Llewellyn won't snooze through tiresome disease
Saturday 14 April 2012
Llewellyn Won't Snooze Through Tiresome Disease
White House Chronicle host Llewellyn King has a fierce new interest: He has become a voice for people who suffer from an incurable disease, myalgic encephalomyelitis, also known as Chronic Fatigue Syndrome.
After writing a slew of columns for the Hearst-New York Times syndicate on Chronic Fatigue Syndrome, and receiving hundreds of letters of gratitude from those who suffer with the disease, he has started a dedicated YouTube channel, MECFSAlert. In various taped episodes, King says he wants to educate people and convince Congress to spend the bucks to find a cure. The channel is also a place for the afflicted to offer one another suggestions and comfort on how to best live with the disease.
“This is right up there with the most important stories I’ve ever covered,” he said. “There are a million victims in the United States – 17 million worldwide – who are the living dead. Their suffering is appalling. They need to be heard in the medical establishment, in Congress and in the general media.”
Want to wind down before your afternoon siesta? Watch him here:
The above, with comments, originally appeared here.
blog comments powered by Disqus